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Abstract
Cellular therapy is a potential approach to improve the regenerative capacity of damaged or diseased skeletal muscle.
However, its clinical use has often been limited by impaired donor cell survival, proliferation and differentiation following
transplantation. Additionally, functional improvements after transplantation are all-too-often negligible. Because the host
microenvironment plays an important role in the fate of transplanted cells, methods to modulate the microenvironment
and guide donor cell behavior are warranted. The purpose of this study was to investigate whether the use of
neuromuscular electrical stimulation (NMES) for 1 or 4 weeks following muscle-derived stem cell (MDSC) transplantation
into dystrophic skeletal muscle can modulate the fate of donor cells and enhance their contribution to muscle regeneration
and functional improvements. Animals submitted to 4 weeks of NMES after transplantation demonstrated a 2-fold increase
in the number of dystrophin+ myofibers as compared to control transplanted muscles. These findings were concomitant
with an increased vascularity in the MDSC+NMES group when compared to non-stimulated counterparts. Additionally,
animals subjected to NMES (with or without MDSC transplantation) presented an increased maximal specific tetanic force
when compared to controls. Although cell transplantation and/or the use of NMES resulted in no changes in fatigue
resistance, the combination of both MDSC transplantation and NMES resulted in a faster recovery from fatigue, when
compared to non-injected and non-stimulated counterparts. We conclude that NMES is a viable method to improve MDSC
engraftment, enhance dystrophic muscle strength, and, in combination with MDSC transplantation, improve recovery from
fatigue. These findings suggest that NMES may be a clinically-relevant adjunct approach for cell transplantation into skeletal
muscle.
Citation: Distefano G, Ferrari RJ, Weiss C, Deasy BM, Boninger ML, et al. (2013) Neuromuscular Electrical Stimulation as a Method to Maximize the Beneficial
Effects of Muscle Stem Cells Transplanted into Dystrophic Skeletal Muscle. PLoS ONE 8(3): e54922. doi:10.1371/journal.pone.0054922
Editor: Antonio Musaro, University of Rome La Sapienza, Italy
Received December 9, 2011; Accepted December 20, 2012; Published March 19, 2013
Copyright:  2013 Distefano et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding Source: - Foundation for Physical Therapy (http://foundation4pt.org/) - NIH K12 for Physical and Occupational Therapists-Comprehensive
Opportunities in Rehabilitation Research Training (K12 HD055931, FA) (http://www.corrt.pitt.edu/) - Competitive Medical Research Fund of the University of
Pittsburgh (http://www.oorhs.pitt.edu/funding/cmrf.aspx) Department of Physical Medicine & Rehabilitation at the University of Pittsburgh (http://www.
rehabmedicine.pitt.edu/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have read the journal’s policy and have the following conflicts: One of the co-authors, Johnny Huard, has a potential financial
conflict of interest because he has received remuneration as a consultant with Cook MyoSite Incorporated during the performance period of this project. None of
the other authors has a financial or other relationship that might lead to conflict of interest concerning the publication of this manuscript. This does not alter the
authors’ adherence to all the PLOS ONE policies on sharing data and materials.
* E-mail: ambrosiof@upmc.edu
Introduction
Cellular therapy is a promising method to enhance skeletal
muscle regeneration after injury or disease. However, the use of
cell therapies for myopathies has often been limited by impaired
donor cell survival [1] and limited functional improvements
following transplantation [2]. An essential role of the muscle
microenvironment on donor cell fate determination has been
suggested [3–5], and it may be argued that the success of cellular
therapies is reliant on the characteristics of the host tissue into
which the cells are introduced [6]. Therefore, a challenge in the
clinical translation of cellular therapies is to develop reasonable
adjunct approaches that modulate the host microenvironment, or
niche, and maximize functional benefits following cell transplan-
tation. The development of clinically relevant approaches to
modulate the niche and optimize cell transplantation is, therefore,
important.
Recent studies realized in our laboratory have shown that motor
unit activation through mechanical stimulation protocols, such as
functional overloading [7] and treadmill running [8], results in
improved vascularity and increased myogenic potential of donor
MDSCs. Similarly, an increased contribution of systemically-
administered bone-marrow derived stem cells (BMDCs) to the
injured muscle has been observed when the muscle was subjected
to treadmill running [9]. Other exercise modalities, such as
swimming, have also demonstrated an enhanced engraftment of
transplanted cells [10]. Taken together, these studies suggest that
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donor stem cells respond to the skeletal muscle needs for
regeneration and/or repair that result from injury or overuse of
the host.
Neuromuscular Electrical Stimulation (NMES) is a common,
inexpensive and safe modality used by physical therapists to
stimulate muscular adaptations, promote angiogenesis, and
increase muscle strength. It also allows for a targeted administra-
tion and physiological response of the specific muscle of interest.
The well-documented ability of NMES to up-regulate VEGF
expression [11,12] further suggests that this modality is a feasible
method to modulate the host microenvironment and donor cell
behavior in cases of muscle injury or pathology.
The purpose of this study was to evaluate the ability of NMES
to modulate the fate of donor cells and enhance their contribution
to muscle regeneration and functional improvements when
transplanted into dystrophic skeletal muscle. While we anticipate
the transplantation alone of wild type MDSC will result in limited
functional benefits of the host muscle, we hypothesize that the
application of NMES will enhance the myogenic potential of
MDSCs and result in an improved functional capacity.
Materials and Methods
MDSC isolation from wild type and dystrophic mice
MDSCs were isolated from skeletal muscle samples obtained
from female 3-week old wild type (C57BL/6J; The Jackson
laboratory, Bar Harbor, ME, USA) mice using a previously
described modified pre-plate technique [13].
Briefly, harvested tissues were immediately placed in saline
solution and finely minced in 16Hank’s Balanced Salt Solution
(HBSS; Invitrogen, 24020). Minced pieces were subsequently
digested using 0.2% Collagenase, Dispase (2.4 units/mL HBSS),
and 0.1% Trypsin. After digestion, the tissue/HBSS solution was
passed through needles ranging in size in order to dissociate any
larger cellular pieces. The solution was then placed into a 25 cm2
collagen-coated culture plate for 2 hours, and transferred to
another 25 cm2 coated culture plate for 24 hours. This step was
repeated an additional four times. The 6th pre-plate population of
cells has been identified as displaying myogenic potential and
immune-privileged behavior [14].
MDSCs were cultured in normal growth medium, consisting of
Dulbecco’s Modified Eagle Medium (Invitrogen, 11995-073)
supplemented with 10% fetal bovine serum, 10% horse serum,
1% penicillin/streptomycin, and 0.5% chick embryo extract
(Gibco-BRL). The cells were maintained in growth medium to
approximately 30% confluence and were subsequently passaged.
Animal care and groups
A total of 36 male dystrophic (mdx) mice with severe combined
immunodeficiency (SCID) (3–5 months old) were used. Mdx mice
lack the protein dystrophin and demonstrate chronic cycles of
active degeneration/regeneration [15], making it a useful model of
Duchenne Muscular Dystrophy to better understand the effects of
host muscle niche on donor stem cell fate. SCID animals were
used in order to minimize the immune rejection against
transplanted MDSC surface antigens.
Mice were housed 4 per cage in a room kept at 20–23uC and a
12:12 h dark-light cycle. Animals had free access to water and
standard chow. This study was performed in accordance with the
recommendations in the Guide for the Care and Use of
Laboratory animals of the National Institutes of Health. All
experiments were approved by the Institutional Animal Care and
Use Committee of Children’s Hospital of Pittsburgh of UPMC.
Animals were randomly divided into the following groups:
Saline controls (PBS, n= 14 muscles), Muscle-Derived Stem Cell
injection (MDSC; n= 16 muscles), Saline + Neuromuscular
Electrical Stimulation (PBS+NMES; n= 16 muscles) and
MDSC+NMES (n= 18 muscles). The NMES interventions were
performed for 1 or 4 weeks, allowing for the investigation of early
and late skeletal muscle responses to MDSC transplantation and
NMES. The muscles collected were evaluated using histology
(n = 5–7 muscles/group) and functional testing (n = 4 muscles/
group)(Figure 1A).
For MDSC transplantation, NMES, and animal sacrifice, mice
were first anesthetized using 2% isofluorane, administered by
inhalation. Following completion of the experimental procedures,
the animals were sacrificed by cervical dislocation.
Cells transduction to express LacZ reporter gene
MDSC were genetically engineered to express nuclear-localized
LacZ (gift from Dr. P. Robbins, University of Pittsburgh) reporter
gene to enable tracking of cells after transplantation. Cells were
transduced with the retroviral vector MFG-NB containing a
modified LacZ gene, which includes a nuclear-localization
sequence cloned from the simian virus 40 (SV40) large tumor
antigen, and is transcribed from the long terminal repeat. Prior to
injection, transduced MDSC were assayed for LacZ expression, as
described previously [16]; 50% of the MDSC population was
positive for LacZ expression immediately prior to injection.
Wild type MDSCs transplantation into dystrophic skeletal
muscle
On the day of injection, MDSCs were trypsinized and spun at
2000 rpm for 5 minutes. The resulting pellet was re-suspended in
phosphate buffered saline (PBS)+0.1% microsphere beads solu-
tion.
Bilateral anterior lower limbs were shaved. Animals in the
MDSC and MDSC+NMES groups received a single intramuscu-
lar injection at the mid-belly (region that has the greatest muscle
girth) of the right tibialis anterior (TA) containing
1.06105 MDSCs suspended in 20 ml of phosphate buffer saline
(PBS)+0.1% fluorescent microsphere bead solution. For PBS and
PBS+NMES groups, left side TAs served as controls, and were
injected with an equal volume of PBS+0.1% fluorescent micro-
sphere beads (Figure 1 A–B). Fluorescent microsphere beads were
used in order to localize the injection site at the time of histological
analysis.
Neuromuscular Electrical Stimulation (NMES)
To investigate the ability of muscle contractile activity to dictate
donor cell behavior in vivo, NMES was performed using a
Neuromuscular Stimulator (Empi 300 PV, St Paul, USA) and
modified surface electrodes, as previously described [17]. Prior to
stimulation, the anterior lower limb was shaved. Location of the
peroneal nerve was confirmed when stimulation resulted in a full
hindlimb dorsiflexion and digit extension, indicating stimulation of
the anterior compartment muscles, including the TA and extensor
digitorum longus (EDL) muscles.
The NMES protocol was initiated 24 hours after MDSC or
PBS injection and was performed 5 days/week for 1 or 4 weeks.
The NMES protocol consisted of 2 sets of 10 contractions. The
parameters used to stimulate the muscles were: pulse duration of
150ms, frequency of 50 Hz, time on: 5 seconds, time off: 10
seconds, 0.5-second ramp and 0.5-second ramp down. NMES
intensity started at 9.0 mA and was gradually increased through-
out the training, to a maximal intensity of 18.0 mA.
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Functional testing
Animals submitted to a 4-week intervention were subjected to a
contractile testing of the lower leg anterior compartment muscles
(TA and EDL) before their muscles were collected for histological
analysis. We did not perform contractile this analysis in the 1-week
treated animals since we did not expect functional improvements
to appear so soon after cell transplantation or NMES interven-
tions. The contractile testing was performed using an in situ testing
apparatus (Model 809B, Aurora Scientific Inc, Canada), a
stimulator (Model 701C, Aurora Scientific Inc, Canada), and a
force transducer (Aurora Scientific Inc, Canada). The method
used allows for the determination of muscle contractile properties
of a muscle of interest, while maintaining normal muscle
orientation, innervation and vascular supply. Briefly, the peroneal
nerve of anesthetized animals was isolated through a small incision
lateral to the knee. Mice were then placed supine on a 37uC
heated platform and the foot being tested was positioned on the
footplate. The hindlimb used for testing was stabilized with cloth
tape on the knee and foot. Muscles were stimulated through the
peroneal nerve by needle electrodes inserted beneath the skin.
Muscle peak twitch, time to peak twitch and half-relaxation
time were evaluated with the ankle positioned at 20u of
plantarflexion, the position which we determined to result in the
greatest force output (data not shown). Tetanic contractions at 10,
30, 50, 80, 100, 120, 150 Hz were elicited to obtain a force-
frequency curve, with a 2-minute rest between each contraction.
The muscles were then subjected to a 7-minute long high-
frequency fatigue protocol consisting of a series of short 350 ms
tetanic contractions at 100 Hz, with 4-second intervals between
contractions [18]. Using this protocol, muscles were stimulated a
total of 105 times during the course of the protocol. Force recovery
was analyzed at 5 and 10 min following completion of the
fatiguing protocol. All surgical procedures and data collection were
performed by the same blinded researcher. Results of single
stimulations, tetanic contraction, fatigue and recovery from fatigue
were collected in torque (milliNm). From torque measurements,
the specific muscle force was obtained by normalizing the absolute
force values (milliN) to the calculated muscle cross-sectional area
(CSA). CSA was calculated as the muscle weight (mg)/muscle
length (mm)6muscle density of 1.06 mg/mm3 [19]. Fatigue and
force recovery data (5 and 10 min) were also expressed as a
percentage of the maximum tetanic force event measured on the
first contraction of the fatiguing protocol.
Histological analysis
After 1 or 4 weeks, animals were sacrificed, and the TA muscles
were harvested and immediately frozen in 2 methyl-butane pre-
cooled in liquid nitrogen and stored at 280uC. Serial cross-
sections (10 mm) were obtained and mounted onto slides.
Immunofluorescent staining for dystrophin positive fibers (dys+),
laminin, CD31 positive cells (as a measure of muscle capillarity),
and embryonic myosin heavy chain (eMHC) were performed.
Additionally, a Hematoxylin & Eosin stain was performed in order
to determine the extent of fiber regeneration and damage, LacZ
Figure 1. Schematic representation of the experimental groups and study design. (A) Schematic representation of the experimental
groups. All interventions were performed for 1 or 4 weeks. For each time point, animals were randomly divided into 2 groups: Sedentary and/or
NMES. For all animals, the left TA was injected with PBS and the right TA injected with MDSC. Muscles were collected for histological (1 and 4 weeks)
and contractile analyses (4 week only). (B) Schematic representation of the experimental design.
doi:10.1371/journal.pone.0054922.g001
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staining was performed to identify transplanted cells, and Masson’s
Trichrome stain was performed to quantify collagen content. All
histological images were photographed and analyzed by a
researcher blinded to the animal grouping.
Immunofluorescent staining. Dystrophin, laminin, and
CD31: Sections were washed with PBS, fixed in 4% formalin for
five minutes, and washed twice in PBS. Nonspecific binding was
then blocked for 1 hour using PBS with 10% Donkey Serum (DS)
or 5% Horse Serum (HS), for dystrophin and laminin, or for
CD31 stains, respectively. Afterward, sections were incubated for
1 hour at room temperature with either a rabbit anti-mouse
polyclonal dystrophin antibody (1:300 dilution in 10% DS), rat
anti-mouse monoclonal laminin antibody (1:300 dilution in 10%
DS), or with a rat anti-mouse primary antibody (1:300 dilution in
5% HS) for CD31 staining. Following 3 PBS washes, anti-
dystrophin sections were treated for 1 hour with a Cy3-labeled
donkey anti-rabbit secondary antibody (1:200 dilution in 10% DS);
anti-laminin sections were treated for 1 hour with an anti-rat
secondary antibody (1:200 dilution in 10% DS); and anti-CD31
sections were treated for 1 hour with a 555-labeled goat anti-rat
secondary antibody (1:300 dilution in 5% HS). Samples were
washed again 3 times in PBS and incubated with the nuclear stain
4’-6-Diamidino-2-phenylindole, DAPI, (1:1000 dilution in PBS).
Embryonic myosin heavy chain: Sections were fixed in 100%
cold methanol at room temperature for five minutes, washed once
in PBS, and incubated with Avidin and Biotin (30 min each).
Mouse on mouse (M.O.M) kit (Vector, BMK-2202) was used
according to manufacturer instructions. Sections were incubated
overnight at 4u with anti-mouse eMHC antibody (Developmental
Studies Hybridoma Bank, University of Iowa; 1:200 dilution in
M.O.M diluent). Sections were then treated for 1 hour at room
temperature with streptavidin anti-mouse (1:200 dilution in
M.O.M diluent). Samples were washed 2 times at 2 minutes with
PBS and incubated with DAPI, (1:1000 dilution in PBS) for 7
minutes.
Quantification of dystrophin positive myofibers and
vascularity. To quantify the total number of dystrophin
positive (dys+) fibers, the entire section containing the most
fluorescent beads was identified and photographed using fluores-
cent microscopy (Nikon Eclipse E800; Japan; 206objective). The
total number of dys+ was manually counted using Northern
Eclipse Software (Empix Imaging Inc.). Similarly, the number of
capillaries was quantified as the total number of CD31 positive
cells in the section containing the most beads. For the MDSC,
PBS+NMES and MDSC+NMES groups, CD31 results are
expressed as fold change compared to PBS control.
Quantification of eMHC positive fibers, myofiber
regeneration and cross-sectional area (CSA). The total
number of eMHC positive fibers in the section containing the
most beads was manually counted using NIS-Elements software
(406 magnification). Additionally, 2 random pictures within the
same section were obtained (406 objective) using a Nikon 90i
motorized upright fluorescent microscopy and the average cross-
sectional area (CSA) of the eMHC positive myofibers were
evaluated using NIS-Elements software. Hematoxylin and Eosin
(H&E) stains were performed in order to quantify the regeneration
index (RI) (total number of centrally located nuclei/total number
of fibers) for each experimental group, as previously described [8].
For each sample, the section containing the most fluorescent beads
was selected and 3 random pictures were obtained (206objective)
using a light microscope (Nikon Eclipse E800; Nikon, Japan). The
total number of fibers and the number of fibers with centrally
located nuclei were manually counted using the National Institutes
of Health (NIH)–developed image analysis software, Image J.
Laminin stains were used to quantify the CSA of the host
myofibers. The entire section containing the most fluorescent
beads was selected and photographed (206 magnification), and
reconstructed using Nikon 90i motorized upright fluorescent
microscopy and NIS-Elements software. A total of 500 fibers per
section were randomly selected and evaluated using Image J. After
CSA analysis, the 500 myofibers evaluated were subdivided in
quartiles according to size and classified as Small, Medium, Large
or Extra large. For each section, the percent of fibers in each one
of the size categories (small, medium, large, and extra large) was
calculated and compared across groups.
Quantification of collagenous tissue. Masson’s Trichrome
staining was performed to quantify the percent of collagen content
and muscle fiber in a muscle section. Slides were processed using
Masson’s Trichrome Stain Kit as per manufacturer’s instructions
(K7228; IMEB, Chicago, IL). This process stains skeletal muscle
fibers red, collagen blue, and nuclei black. For each sample, the
section containing the most fluorescent beads was selected and
photographed using Nikon 90i motorized upright fluorescent
microscopy and NIS-Elements. The percentage of the total
collagen-positive area relative to the total cross-sectional area
was calculated. For determination of collagen content, sections
were analyzed using MetaMorph Offline.
Transplanted MDSC tracking through LacZ
detection. Muscle sections were fixed with 1% glutaraldehyde
(Sigma Chemical, St. Louis, MO) and were incubated with LacZ
staining solution (0.5M K4Fe[CN]6, 0.5M K3Fe[CN]6, and 1.0M
MgCl2) for 2 h at 37uC, as previously described [20]. The sections
were subsequently stained with eosin.
For the muscle samples transplanted with MDSC, the total
number of LacZ-positive cells within a muscle section was
manually counted (106 objective) using ImageJ. A total of 15
muscle sections (200 mm apart), representing about 25% of the
total muscle length (3 mm), were analyzed. In addition, in order to
determine the percentage of LacZ-positive cells that were
terminally differentiated towards a myogenic lineage, co-localiza-
tion of LacZ and laminin was performed. The number of LacZ-
positive cells contained clearly within the borders of a myofiber
(defined by Laminin stain) was manually counted using a 206
objective, divided by the total number of LacZ-positive cells within
the field of view, and expressed as a percentage.
Statistics
All analyses were performed using standard statistical software
packages (SPSS v17.0 software, Chicago, IL). Results are
expressed as mean 6 standard deviation. Shapiro-Wilk test was
performed to assess normality of data, and Levene’s test was used
to check equality of variances. One-Way ANOVA and Kruskal-
Wallis tests were used to compare differences across groups, with
subsequent post-hoc Tukey and Mann-Whitney U tests, as
appropriate. Independent t-test was performed to compare 1-
and 4-week results within groups, as well as to compare LacZ
results between MDSC and MDSC+NMES groups. To investi-
gate the relationship between vascularity and the number of
engrafted donor cells, a Pearson correlation was performed.
Multivariate ANOVA was used to evaluate CSA of the host
myofibers. One animal presented a score (total number of LacZ-
positive cells within a muscle section) that was greater than 2
standard deviations outside the mean. Therefore, he was
considered an outlier and was not included in the LacZ analysis.
Statistical significance was established, a priori, at p#0.05.
Electrical Stimulation and Cell Transplantation
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Results
Four weeks of NMES increases the number of CD31
positive cells
No differences were observed in the total number of CD31
positive cells between PBS and MDSC groups, at either 1 or 4
weeks after transplantation (PBS 1W: 1; MDSC 1w: 0.9760.16;
p = 0.602; PBS 4w: 1; MDSC 4w: 1.3360.19; p = 0.286;
figure 2A–B), suggesting that, for the dose and timing protocol
used in this experiment, MDSC transplantation alone was not
sufficient to significantly stimulate angiogenesis.
Similarly, one week of NMES did not promote significant
changes in vascularity, as evidenced by the number of CD31
positive cells (PBS: 1; PBS+NMES: 1.0560.05; MDSC+NMES:
1.0660.14; p.0.273; figure 2A–B). On the other hand, 4 weeks of
NMES resulted in a significant fold increase in the CD31 positive
cells in the PBS+NMES and MDSC+NMES groups when
compared to PBS and MDSC only groups (PBS: 1; MDSC:
1.3360.19; PBS+NMES: 2.2060.24; MDSC+NMES: 2.1660.26;
p,0.001; figure 2A–B).
Four weeks of NMES increases the myogenic
differentiation of transplanted MDSC
Since dystrophic animals largely lack dystrophin expression,
quantification of the number of dys+ fibers present in the host after
MDSC transplantation is an accepted method to evaluate the
myogenic potential of donor MDSC. As expected, a significant
increase in the number of dys+ fibers was observed in the MDSC
group when compared to PBS group both 1 and 4 weeks after
transplantation, (PBS 1w: 31611; MDSC 1w: 88635; p = 0.002;
PBS 4w: 2861; MDSC 4w: 123641; p= 0.034; figure 3),
confirming the potential of donor cells to differentiate towards a
myogenic lineage. However, no significant differences were found
in the total number of dys+ fibers in the MDSC groups between 1
and 4 weeks (p = 0.215).
On the other hand, 4 weeks of NMES following MDSC
transplantation resulted in a 2-fold increase in the number of dys+
fibers when compared to MDSC control group (MDSC: 123641;
MDSC+NMES: 260660; p= 0.014; figure 3A–B), suggesting that
NMES significantly increased the myogenic differentiation of
transplanted MDSCs. Moreover, while there was no relationship
between muscle vascularity and the number of dys+ fibers after 1
week (R2 = 0.0121; p= 0.374) we did observe a significant positive
correlation between the number of dys+ and CD31+ cells across
our 4-week transplantation groups (R2 = 0.655; p = 0.004)
(Figure 3C).
Given the increased number of dys+ fibers following NMES as
compared to control counterparts at the later timepoint, we then
compared the total number of LacZ-positive cells across a total
distance of 3 mm in the MDSC and MDSC+NMES groups. After
4 weeks, there was a significant increase in the total number of
LacZ-positive cells following completion of an NMES protocol,
when compared to MDSC transplantation alone (MDSC:
207961006; MDSC+NMES: 443862185; p = 0.03; figure 4A–B).
Additionally, approximately 64% and 77% of the LacZ cells
were co-localized within myofibers for both MDSC and
MDSC+NMES groups, respectively (Figure 4C). The remainder
of the LacZ-positive cells appeared to be localized to the cellular
infiltrate at the transplantation site. To investigate whether the
use of NMES resulted in larger LacZ positive myofibers we also
evaluated the cross-sectional area of the LacZ positive fibers. No
differences were observed in the CSA of LacZ positive
myofibers when comparing across MDSC and MDSC+NMES
groups (MDSC: 757.836153.88 mm; MDSC+NMES:
774.486181.39 mm; p = 0.893).
Four weeks of NMES increases the number, but not the
CSA, of eMHC muscle fibers
A significant increase in the number of eMHC myofibers was
observed in the MDSC group when compared to PBS group, both
1 and 4 weeks after transplantation (PBS 1w: 946146; MDSC 1w:
4966136; p = 0.007; PBS 4w: 1266131; MDSC 4w: 8526275;
p = 0.004). Despite the fact that no significant differences were
observed between MDSC and MDSC+NMES groups 1 week after
transplantation (MDSC 1w: 4966136; MDSC+NMES 1w:
5326230; p = 0.983), animals submitted to 4 weeks of NMES
presented an increased number of eMHC positive myofibers when
compared to MDSC (MDSC 4w: 8526275; MDSC+NMES 4w:
13516387; p= 0.016).
No differences were observed in the CSA of eMHC positive
myofibers between the groups either 1 (PBS 1w: 181671; MDSC
Figure 2. Effect of in vivo MDSC transplantation and NMES on
CD31 positive cells in dystrophic muscles. (A) Fold change in
CD31+ cells on MDSC, PBS+NMES and MDSC+NMES groups, when
compared to PBS injected controls (n = 5–6/group). (B) CD31 immuno-
staining in the tissue cross-sections of TA muscles across experimental
groups (206 magnification). * Denotes significantly different when
compared to MDSC 4 week (p,0.05).
doi:10.1371/journal.pone.0054922.g002
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1w: 152649; PBS+NMES 1w: 115622; MDSC+NMES 1w:
148645; p= 0.278) or 4 weeks (PBS 4w: 183671; MDSC 4w:
171629; PBS+NMES 4w: 170644; MDSC+NMES 4w: 146636;
p = 0.489) after transplantation.
Muscle regeneration, myofiber CSA and fibrosis
formation were not influenced by NMES
One week after MDSC transplantation, there was a significant
decrease in the regeneration index of both MDSC and
MDSC+NMES groups, when compared to PBS and PBS+NMES
controls (MDSC: 0.6760.05; MDSC+NMES: 0.6960.06;
PBS:0.8660.03; PBS+NMES: 0.8860.01; p,0.01; Figure 5).
Animals transplanted with MDSC showed a non- significant
increase in the total number of muscle fibers per field analyzed
(p = 0.463), as well as a non-significant decrease in the total
number of fibers with central nuclei (p = 0.068), therefore leading
to a significant decrease in the regeneration index (total number of
centrally nucleated fibers/total number of fibers). However, 4
weeks after MDSC transplantation, no differences were observed
in the regeneration index of the groups (Figure 5). These findings
may suggest that, early after transplantation, donor cells may
interfere with the degeneration/regeneration cycles typical of
dystrophic muscle, but this effect is not sustained at later time
points.
Four weeks after MDSC transplantation and/or NMES, no
differences were observed in the distribution of ‘Small’, ‘Medium’,
‘Large’, or ‘Extra-large’ fibers (Small, p = 0.819; Medium,
p= 0.206; Large, p = 0.714; Extra-large, p= 0.250; figure 6A).
Similarly, no differences in the percentage of collagenous tissue
(PBS: 15.3660.96; MDSC: 12.7061.6; NMES: 12.6863.9;
MDSC+NMES: 13.4665.29; p= 0.567; Figure 6B–C) were
observed between the groups.
NMES and/or the combination of MDSC and NMES
improve contractile characteristics
Contractile testing showed no differences in maximal twitch
torque (p = 0.053), specific twitch force (p = 0.540), time to peak
twitch (p = 0.627), or half relaxation time (p= 0.432) between
groups (Table 1).
No differences were observed in the maximum tetanic torque
between groups (150 Hz; p = 0.369), however, there was a
significant increase in the specific tetanic force (150 Hz) in both
the PBS+NMES and MDSC+NMES groups, when compared to
PBS (PBS: 11.3061.50 milliN/mm2; MDSC: 13.7661.95 milliN/
mm2; PBS+NMES: 15.2260.89 milliN/mm2; MDSC+NMES:
16.1962.48 milliN/mm2; p,0.036) (Table 1). No differences were
found between PBS+NMES and MDSC+NMES groups
(p = 0.881), suggesting that the transplanted cells did not
contribute to the increased specific tetanic force at the time-point
investigated.
While no differences were found in the resistance to fatigue
between the groups (PBS: 38617%; MDSC: 5162.5%;
Figure 3. Effect of in vivo MDSC transplantation and NMES on the number of dystrophin positive fibers in dystrophic muscles. (A)
Total number of dys+ in each of the experimental groups (n = 5–6/group). (B) Dystrophin immunostaining in the tissue cross-sections of TA muscles
of mdx mice 4 weeks after transplantation (406magnification). (C) Correlation between the number of dys+ and CD31+ cells across our 4week
transplantation groups (R2 = 0.655; p = 0.004; n = 9). * Denotes significantly different when compared to PBS counterparts control (p,0.05). 1 Denotes
significantly different when compared to MDSC 4-week group (p,0.05).
doi:10.1371/journal.pone.0054922.g003
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PBS+NMES: 47621%; MDSC+NMES: 46611%, p= 0.507;
figure 7B), muscles transplanted with MDSC demonstrated a
non-significant trend to a faster recovery from fatigue, showing a
near complete recovery from fatigue after 5 minutes of the end of
the protocol when compared to PBS control (PBS: 67%611%;
MDSC: 96%613%; NMES: 68%626; MDSC+NMES:
93%612%; p= 0.112) (Figure 7C).
Animals receiving a combination of both MDSC transplanta-
tion and NMES presented a significantly improved recovery from
fatigue at both 5 (Specific tetanic force: PBS: 7.8761.83 milliN/
mm2; MDSC: 12.1961.2 milliN/mm2; NMES: 9.6363.9 milliN/
mm2; MDSC+NMES: 15.9664.14 milliN/mm2, p= 0.018) and
10 min (PBS: 10.1362.07 milliN/mm2; MDSC: 13.1161.81
milliN/mm2; NMES: 10.8863.56 milliN/mm2; MDSC+NMES:
1762.76 milliN/mm2, p = 0.025), when compared to PBS group,
figure 7D.
Discussion
The host microenvironment plays an essential role in deter-
mining transplanted cell fate, supporting the importance of
optimizing the niche to maximize the efficacy of cellular therapies
[2–4]. Given the chronic myofiber degeneration/regeneration
cycles occurring within dystrophic muscles, and the replacement of
healthy muscle into adipose and scar tissue, this represents a
hostile environment for cell transplantation. Modulation of the
microenvironment has the potential to provide muscle stems cells
(both host and donor) with support factors necessary to promote
survival and improve myogenic capacity. Our results suggest that
wild type MDSC transplantation alone results in a limited cell
engraftment and no significant increase in muscle strength.
Conversely, the addition of NMES improves the myogenic
potential of donor cells and enhances the peak tetanic strength
of the dystrophic muscle. Only a combination therapy consisting
of both cell transplantation and NMES resulted in a faster muscle
recovery from fatigue when compared to controls.
Previous studies performed in our laboratory have demonstrat-
ed the ability of mechanical stimulation, such as functional
overloading (which involves surgical ablation of the synergistic
muscle) [7] and treadmill running [8], to improve MDSC
engraftment following transplantation. Each of these methods,
however, has their limitations. The ablation of a muscle to
produce overloading is not a clinically desirable option and a high
intensity exercise such as treadmill running may not be feasible in
the case of myopathies or severe muscle injuries where overexer-
tion may only exacerbate the pathology. NMES offers the
advantage of being a widely used, safe, and inexpensive
rehabilitation modality that may be applied in the case of many
muscular diseases as well as for individuals not able to participate
in exercise protocols.
In the current experiment, although 1 week of NMES did not
affect donor cell engraftment, 4 weeks of NMES stimulated a
significant increase in the myogenic differentiation of donor cells,
as determined by the average number of dys+ myofibers/cross-
section. Consistent with previous animal studies [7,16,21], the
current findings also demonstrated a direct relationship between
Figure 4. LacZ positive cells among experimental groups. (A) Total number of LacZ positive cells (B) LacZ distribution in the MDSC and
MDSC+NMES 4-week groups across 4 mm of the muscle (n = 6–7/group). (C) LacZ, laminin and dystrophin staining in the tissue cross-sections of TA
muscles in MDSC and MDSC+NMES 4-week groups (606magnification, scale bar = 10 mm). * Denotes significantly different when compared to PBS 1-
week control (p,0.05). 1 Denotes significantly different when compared to PBS 4-week group (p,0.05).
doi:10.1371/journal.pone.0054922.g004
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vascularity and donor cell engraftment (R2 = 0.655; p = 0.004). In
a recent paper by Gargioli and colleagues [22], authors
demonstrated an increased engraftment efficiency of tendon
fibroblasts injected into aged dystrophic muscle when the
fibroblasts were modified to express a pro-angiogenic factor. They
hypothesized that donor cells survive better in a blood vessel-rich
environment, supporting the role of the muscle microenvironment
on stem cell transplantation efficiency. Of note, we observed no
additive effect of NMES and MDSC transplantation on skeletal
muscle vascularity, suggesting that the presence of transplanted
MDSCs themselves did not significantly contribute to angiogen-
esis. The effects of NMES on muscle vascularity and the secretion
of myogenically favorable growth factors, however, has been
widely documented, further supporting its role as an adjunct
therapy to cell transplantation [11,23]. Future mechanistic studies
should investigate whether targeted inhibition of NMES-induced
angiogenesis, such as through the administration of sFLT1, a
VEGF antagonist, would abrogate the beneficial effect of NMES
on cell transplantation and muscle function.
In addition to the vascular changes observed, we found that the
application of NMES, both in the presence and in the absence of
donor cells, enhanced the specific tetanic force of dystrophic
muscles when compared to PBS- or MDSC-injected muscles.
These findings suggest that NMES may represent a clinically-
relevant method to improve the muscle strength of dystrophic
muscle. NMES has been shown to recruit motor units in a non-
specific and temporally synchronous manner [24]. Therefore, the
beneficial effect of NMES on force production may be attributed
to increased neural activation, consistent with previous reports.
This would also help explain why increases in force were not
concomitant with an increased myofiber hypertrophy of NMES-
treated muscles. However, we did not observe a further increase in
Figure 5. Effect of in vivoMDSC transplantation and NMES onmuscle regeneration. (A) Total number of eMHC positive myofiber/section in
each experimental group (n = 5–6/group). (B) Regeneration index (total number of regenerating fibers/total number of fibers) between experimental
groups at 1 and 4 weeks (n = 5–6/group). (C) eMHC staining in the tissue cross-sections of TA muscles of mdx mice 4 weeks after MDSC
transplantation (406magnification, scale bar = 20 mm). (D) Hematoxylin & Eosin staining in the tissue cross-sections of TA muscles of mdx mice 1 and
4 weeks after transplantation (206magnification). * Denotes significantly different when compared to PBS 1-week control (p,0.05).
doi:10.1371/journal.pone.0054922.g005
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skeletal muscle strength when NMES was coupled with MDSC
transplantation. Qualitatively, it is clear that, even 4 weeks after
transplantation, donor fibers are very small in diameter. It is
possible that longer evaluation time points are necessary to allow
for donor fibers to mature, hypertrophy, and more effectively
contribute to an overall enhanced skeletal muscle function. Given
the majority of the donor cells present within the muscle were still
contained within small, nascent myotubes, it is likely that these
nascent donor fibers are not yet innervated and, therefore, do not
possess the capacity to contribute to functional improvements. To
the best of our knowledge, no studies to date have investigated the
innervation status of MDSC-derived fibers following transplanta-
tion. This should be the topic of future investigations.
Neither NMES nor stem cell transplantation, in isolation or in
conjunction, had any effect on the fatigue resistance of dystrophic
muscles. However, animals transplanted with MDSC did demon-
strate a trend towards a faster recovery from fatigue after 4 weeks,
when compared to control counterparts (Figure 7C), and both
MDSC-treated groups (MDSC and MDSC+NMES) almost
completely recovered to baseline strength after 5 minutes.
However, only the combination of MDSC transplantation and
Figure 6. Effect of in vivo MDSC transplantation and NMES on cross-sectional area of host myofibers and percent of collagenous
tissue. (A) Distribution of myofibers in each group classified as ‘small’, ‘medium’, ‘large’ and ‘extra-large’, expressed as percentage. (B) Percent of
collagenous tissue across experimental groups. (C) Masson’s Trichrome stain in the tissue cross-sections of TA muscles of mdx mice 4 weeks after
transplantation (206magnification, scale bar = 100 mm).
doi:10.1371/journal.pone.0054922.g006
Table 1. Contractile characteristics.
PBS MDSC NMES MDSC+NMES
Mice (n) 4 4 4 4
Muscle weight (mg) 80.663.47 69.464.0 7269.6 63.4613
Muscle length (mm) 11.5760.06 11.4960.06 11.6660.26 11.3860.27
CSA (mm2) 6.5760.31 5.760.34 5.860.69 5.260.95
Maximum twitch torque (MilliN m) 0.73560.151 0.60460.045 0.74860.106 0.59860.069
Maximum tetanic torque, 150 Hz (MilliN m) 2.2460.39 2.3460.32 2.6660.39 2.3360.05
Specific twitch force (MilliN/mm2) 3.7160.67 3.5460.30 4.2860.14 3.9861.28
Specific tetanic force, 150 Hz (MilliN/mm2) 11.3061.50 13.7661.95 15.2260.89* 16.1962.48*
Time to peak twitch (ms) 2864.9 2663.2 3063.4 2765.6
Half relaxation time (ms) 2264.8 2264.3 2867.1 2266.3
*Denotes significantly different when compared to PBS (p,0.05).
doi:10.1371/journal.pone.0054922.t001
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NMES resulted in a significantly increased maximal tetanic force
both 5 and 10 min after cessation of a fatiguing protocol.
It has been previously reported that dystrophic muscles
demonstrate not only a decreased resistance to fatigue, but also
an impaired fatigue recovery, as evidenced by a persistent muscle
acidosis following a fatiguing protocol [25]. This impaired fatigue
recovery implies a metabolic dysfunction of dystrophic muscles.
Indeed, structures associated with proton expulsion following
completion of a contractile protocol have been localized to the
myofiber membrane, and therefore, dystrophin [25]. Our current
results suggest that MDSC transplantation may help overcome this
dysfunction by allowing the muscle to more rapidly return to
baseline force-producing capacity. This finding is important
considering fatigue is a prominent and common symptom for
individuals with muscular dystrophy, and one that oftentimes
limits their ability to participate in activities of daily living.
Adequate physical functioning is reliant both on an individual’s
ability to produce a sufficient force to perform daily task and the
individual’s ability to sustain tasks over time. Therefore, improve-
ments in a muscle’s ability to recover from a fatiguing activity
could ultimately translate to an enhanced quality of life. The
mechanisms, however, underlying the MDSC-mediated hastened
muscle recovery remain unclear. Further studies should be
performed to better understand the metabolic dysregulation of
dystrophic muscles following a fatiguing protocol, and as well as
the capacity of transplanted cells to ameliorate these effects.
Interestingly, it was only when we administered both NMES
and MDSC transplantation that we observed significant increases
in both strength and fatigue recovery, as compared to controls. It
appears that the application of NMES (independent of MDSC
transplantation) increased the overall force-producing capacity of
dystrophic muscle, whereas MDSC transplantation accelerated the
muscle’s capacity to return to maximal capacity after a fatigue
protocol. These results suggest a synergistic effect of NMES and
MDSC transplantation to promote an overall functional improve-
ment of dystrophic muscle. As biological therapies are being
translated to the clinic, increasing attention should be paid towards
the development of comprehensive clinical care plans that will
maximize the overall therapeutic benefit of the intervention. This
involves not only optimization of stem cell transplantation
protocols and methods to maximize transplantation efficiency,
but also careful attention to the development of targeted and
specific rehabilitation protocols designed to promote maximal
muscle function.
A limitation of this study is that the analysis of contractile
function and histological characteristics did not extend beyond 4
weeks. As such, it is unclear whether any beneficial effects of
NMES or MDSC transplantation may persist, increase or decrease
over time. We observed, for example, that 4 weeks after
transplantation, approximately 30% of the transplanted cells were
found outside of the muscle fibers. Since the LacZ nuclei are
largely intact, we expect that the cells are still viable. However, it is
not known whether these cells differentiated into fibrotic tissue [3]
or if they are still undifferentiated. The observed increase in the
dys+ and eMHC positive cells between 1 and 4 weeks suggests that
at least a portion of the donor cells are still in a stage of
proliferative expansion and are not yet differentiated.
An improved understanding of mechanisms underlying the
beneficial effects observed in these experiments would aid in the
optimization of NMES and transplantation protocols. The present
experiment demonstrates a proof-of-principle that mechanical
stimulation using NMES may be an effective method to dictate the
Figure 7. In situ contractile testing of the lower leg anterior compartment muscles (n=4 per group). (A) Force-frequency curve. (B)
Resistance to a 7-min fatigue protocol. Data are presented as percent force decrease compared to the first muscle contraction. (C) Recovery from
fatigue after 5 and 10 minutes. Data are presented as percent force compared to the initial muscle contraction at the start of the fatigue protocol. (D)
Recovery from fatigue after 5 and 10 minutes, expressed as specific tetanic force. * Different when compared to PBS and NMES groups (p,0.05).
doi:10.1371/journal.pone.0054922.g007
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behavior of donor cells, even after transplantation. Future studies
should investigate whether other cell populations considered for
cellular therapies are similarly responsive to NMES.
Taken together, our results suggest that modulation of the niche
by NMES enhances both transplanted cell engraftment and
strength of dystrophic muscle. Additionally, a combination
therapy of NMES and MDSC results in a significant improvement
in muscle force recovery following a fatigue protocol.
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